Finance

Lists
BDX:NYSE
Becton Dickinson and Co
188,55 US$
-0,18%
(-0,34) 1D
13 ოქტ, 09:36:28 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BDX...
Open
189,82 US$
High
189,82 US$
Low
188,55 US$
Mkt. cap
51,36 მლრდ.
Avg. vol.
1,78 მლნ.
Volume
1,11 ათ.
Dividend
2,23%
Quarterly dividend
1,05 US$
Ex-dividend date
9 სექ. 2026
P/E ratio
56,96
52-wk high
193,07 US$
52-wk low
127,54 US$
EPS
3,31 US$
Beta
0,21
Shares outstanding
272,39 მლნ.
No. of employees
72 ათ.
Open
189,82 US$
High
189,82 US$
Low
188,55 US$
Mkt. cap
51,36 მლრდ.
Avg. vol.
1,78 მლნ.
Volume
1,11 ათ.
Dividend
2,23%
Quarterly dividend
1,05 US$
Ex-dividend date
9 სექ. 2026
P/E ratio
56,96
52-wk high
193,07 US$
52-wk low
127,54 US$
EPS
3,31 US$
Beta
0,21
Shares outstanding
272,39 მლნ.
No. of employees
72 ათ.
News stories
From web sources and news partners
Profile
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas. BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023. Wikipedia
About Becton Dickinson and Co
CEOთომას პოლენ
Employees72 ათ.
Founded1897
HeadquartersFranklin Lakes, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorMedical device
Websitebd.com
Analyst ratings
Based on 10 analysts giving stock ratings to BDX in the past 3 months
Buy
Buy
4
Hold
5
Sell
1
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for BDX in the last 3 months.
Highest
Current 188,55 US$
210,00 US$ (+11,38%)
Average
191,80 US$ (+1,72%)
Lowest
165,00 US$ (-12,49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Hold
Maintained
200,00 US$
+6,1%
10/06/2026
Christopher Pasquale
Barclays
Sell
Initiated
165,00 US$
-12,5%
10/07/2026
Matt Miksic
Barclays
Sell
Maintained
165,00 US$
-12,5%
10/07/2026
Joanne Wuensch
Citi
Buy
Maintained
208,00 US$
+10,3%
10/05/2026
Kendall Au
RBC Capital
Hold
Maintained
190,00 US$
+0,8%
10/01/2026
Matthew Taylor
Jefferies
Buy
Maintained
210,00 US$
+11,4%
09/08/2026
Josh Jennings
TD Cowen
Hold
Reiterated
182,00 US$
-3,5%
08/17/2026
Patrick Wood
UBS
Buy
Reiterated
205,00 US$
+8,7%
08/12/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
188,00 US$
-0,3%
08/10/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
195,00 US$
+3,4%
08/11/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
175,00 US$
-7,2%
08/07/2026
Shagun Singh Chadha
RBC Capital
Hold
Maintained
180,00 US$
-4,5%
08/06/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
180,00 US$
-4,5%
07/06/2026
David Roman
Goldman Sachs
Hold
Initiated
167,00 US$
-11,4%
04/10/2026
David Toung
Argus Research
Buy
Reiterated
180,00 US$
-4,5%
03/20/2026
Unknown Analyst
Jefferies
Buy
Maintained
190,00 US$
+0,8%
02/10/2026
Unknown Analyst
J.P. Morgan
Hold
Maintained
175,00 US$
-7,2%
02/10/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
157,00 US$
-16,7%
02/10/2026
Last report
6 აგვ. 2026
Fiscal period
Q3 2026
3,23 US$ / 3,14 US$
+2,93%beat
Revenue / Est. (USD)
4,98 მლრდ. / 4,89 მლრდ.
+1,91%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,89 მლრდ.
4,49 მლრდ.
4,71 მლრდ.
4,98 მლრდ.
Cost of goods sold
3,09 მლრდ.
2,43 მლრდ.
2,56 მლრდ.
2,67 მლრდ.
Cost of revenue
3,09 მლრდ.
2,43 მლრდ.
2,56 მლრდ.
2,67 მლრდ.
Research and development expenses
322,00 მლნ.
235,00 მლნ.
249,00 მლნ.
258,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,43 მლრდ.
1,23 მლრდ.
1,24 მლრდ.
1,27 მლრდ.
Operating expense
1,75 მლრდ.
1,46 მლრდ.
1,46 მლრდ.
1,53 მლრდ.
Total operating expenses
4,84 მლრდ.
3,90 მლრდ.
4,02 მლრდ.
4,20 მლრდ.
Operating income
1,05 მლრდ.
590,00 მლნ.
695,00 მლნ.
784,00 მლნ.
Other non operating income
92,00 მლნ.
-12,00 მლნ.
109,00 მლნ.
30,00 მლნ.
EBT including unusual items
510,00 მლნ.
311,00 მლნ.
39,00 მლნ.
553,00 მლნ.
EBT excluding unusual items
947,00 მლნ.
429,00 მლნ.
664,00 მლნ.
686,00 მლნ.
Income tax expense
17,00 მლნ.
-
76,00 მლნ.
102,00 მლნ.
Effective tax rate
3,33%
-
194,87%
18,44%
Other operating expenses
-4,00 მლნ.
1,00 მლნ.
-26,00 მლნ.
-
Net income
493,00 მლნ.
383,00 მლნ.
-311,00 მლნ.
377,00 მლნ.
Net profit margin
8,37%
8,54%
-6,60%
7,57%
Earnings per share
3,96
2,91
2,90
3,23
Interest and investment income
5,00 მლნ.
4,00 მლნ.
9,00 მლნ.
4,00 მლნ.
Interest expense
-155,00 მლნ.
-153,00 მლნ.
-149,00 მლნ.
-132,00 მლნ.
Net interest expenses
-150,00 მლნ.
-149,00 მლნ.
-140,00 მლნ.
-128,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,68 მლრდ.
1,20 მლრდ.
1,22 მლრდ.
1,35 მლრდ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები